AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 81 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $26,862 | -72.0% | 11,679 | -42.0% | 0.00% | – |
| Q4 2021 | $96,000 | -52.2% | 20,139 | -20.5% | 0.00% | – |
| Q3 2021 | $201,000 | +8.6% | 25,323 | -4.5% | 0.00% | – |
| Q2 2021 | $185,000 | -19.6% | 26,523 | -8.8% | 0.00% | – |
| Q1 2021 | $230,000 | +0.4% | 29,097 | -0.1% | 0.00% | – |
| Q4 2020 | $229,000 | +25.1% | 29,124 | +13.1% | 0.00% | – |
| Q3 2020 | $183,000 | -22.5% | 25,754 | 0.0% | 0.00% | – |
| Q2 2020 | $236,000 | +171.3% | 25,754 | +38.6% | 0.00% | – |
| Q1 2020 | $87,000 | -34.6% | 18,583 | +6.8% | 0.00% | – |
| Q4 2019 | $133,000 | -11.3% | 17,398 | -11.3% | 0.00% | – |
| Q3 2019 | $150,000 | +11.9% | 19,622 | +0.5% | 0.00% | – |
| Q2 2019 | $134,000 | -7.6% | 19,526 | +42.0% | 0.00% | – |
| Q2 2018 | $145,000 | – | 13,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |